VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CABA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CABACabaletta Bio, Inc.
$3.10$505M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCABAQuarterly Financials

Cabaletta Bio, Inc. (CABA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cabaletta Bio, Inc. (CABA) quarterly income statement — complete revenue, gross profit & net income history

CABA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses44.3M42.61M46.59M45.91M37.14M33.78M33.05M30.28M28.03M23.15M18.67M15.89M16.96M16.3M11.78M13.06M13M13.89M11.56M11.14M
OpEx % of Revenue--------------------
Selling, General & Admin6.94M6.42M6.76M8.27M8.12M8.25M6.76M6.85M6.08M5.74M4.88M4.09M4.52M3.9M3.56M3.55M3.83M3.97M3.39M3.29M
SG&A % of Revenue--------------------
Research & Development37.35M36.19M39.82M37.64M29.02M25.53M26.29M23.43M21.95M17.41M13.79M11.8M12.44M12.4M8.22M9.51M9.17M9.92M8.17M7.85M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-44.3M-42.61M-46.59M-45.91M-37.14M-33.78M-33.05M-30.28M-28.03M-23.15M-18.67M-15.89M-16.96M-16.3M-11.78M-13.06M-13M-13.89M-11.56M-11.14M
Operating Margin %--------------------
Operating Income Growth %-19.28%-26.12%-40.98%-51.61%-32.48%-45.96%-77.02%-90.55%-65.32%-41.98%-58.5%-21.67%-30.44%-17.34%-1.86%-17.18%-33.84%-48.91%-37.39%-36.05%
EBITDA-43.96M-42.26M-46.24M-45.44M-36.65M-33.32M-32.62M-29.85M-27.64M-22.81M-18.31M-15.52M-16.59M-15.94M-11.41M-12.82M-12.78M-13.66M-11.34M-10.98M
EBITDA Margin %--------------------
EBITDA Growth %-19.94%-26.85%-41.75%-52.21%-32.61%-46.06%-78.14%-92.35%-66.58%-43.06%-60.43%-21.04%-29.82%-16.73%-0.64%-16.74%-33.18%-48.15%-36.22%-35.36%
D&A (Non-Cash Add-back)337K348K345K468K485K468K424K426K393K336K355K370K365K358K363K238K219K234K221K162K
EBIT-42.88M-41.36M-44.28M-44.56M-35.65M-23.76M-30.63M-27.6M-25.05M-23.15M-18.67M-15.89M-16.96M-16.3M-11.78M-13.06M-13M-13.89M-11.56M-11.14M
Net Interest Income440K771K1.22M839K1.19M1.2M2.42M2.68M2.98M2.26M2.22M1.4M1.1M610K351K150K53K5K3K6K
Interest Income1.08M1.33M1.81M1.41M1.49M1.95M2.42M2.68M2.98M2.26M2.22M1.4M1.1M610K351K150K53K5K3K6K
Interest Expense636K555K584K571K294K748K00000000000000
Other Income/Expense781K692K1.72M778K1.19M1.2M2.42M2.68M2.98M2.26M2.22M1.4M1.1M610K351K150K53K5K3K6K
Pretax Income-43.52M-41.92M-44.87M-45.13M-35.94M-32.59M-30.63M-27.6M-25.05M-20.89M-16.45M-14.49M-15.85M-15.69M-11.43M-12.91M-12.95M-13.89M-11.56M-11.14M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-43.52M-41.92M-44.87M-45.13M-35.94M-32.59M-30.63M-27.6M-25.05M-20.89M-16.45M-14.49M-15.85M-15.69M-11.43M-12.91M-12.95M-13.89M-11.56M-11.14M
Net Margin %--------------------
Net Income Growth %-21.07%-28.64%-46.48%-63.5%-43.5%-56.02%-86.22%-90.53%-57.99%-33.1%-43.94%-12.22%-22.46%-12.99%1.15%-15.9%-33.44%-49.19%-37.73%-36.64%
Net Income (Continuing)-43.52M-41.92M-44.87M-45.13M-35.94M-32.59M-30.63M-27.6M-25.05M-20.89M-16.45M-14.49M-15.85M-15.69M-11.43M-12.91M-12.95M-13.89M-11.56M-11.14M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.39-0.41-0.44-0.73-0.73-0.65-0.62-0.56-0.51-0.47-0.37-0.37-0.42-0.51-0.38-0.44-0.45-0.49-0.45-0.45
EPS Growth %46.58%36.92%29.03%-30.36%-43.14%-38.3%-67.57%-51.35%-21.43%7.84%2.63%15.91%6.67%-4.08%15.56%2.22%-9.76%-22.5%-25%-28.57%
EPS (Basic)-0.39-0.41-0.44-0.73-0.73-0.65-0.63-0.56-0.50-0.47-0.37-0.37-0.45-0.51-0.38-0.44-0.45-0.49-0.45-0.55
Diluted Shares Outstanding112.03M102.26M102.26M61.88M49.47M50.2M49.47M49.45M49.3M44.44M43.96M39.17M35.45M29.45M29.01M28.99M28.96M28.34M25.85M24.73M
Basic Shares Outstanding112.03M102.26M102.26M61.88M49.52M50.13M48.94M48.94M49.3M44.44M43.96M39.17M33.59M29.45M29.01M28.99M28.96M28.34M25.85M20.42M
Dividend Payout Ratio--------------------